N.S. couple seeks to save dog from cancer using stem cell treatment only available in U.S.
When five-year-old golden doodle, Lucy, was diagnosed with T-cell lymphoma, owners Stéphanie Gauvin and Tim MacIsaac knew ...
Business Insider12h
Arvinas initiated with an Overweight at Stephens
Stephens initiated coverage of Arvinas (ARVN) with an Overweight rating and $55 price target. The firm is adding to its Biotechnology research coverage with a focus on targeted protein degradation, or ...